genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

In vitro assays

Endpoints: Considerations for Hit to Lead Selection of a Bispecific Antibody in Oncology
Cancer

Endpoints: Considerations for Hit to Lead Selection of a Bispecific Antibody in Oncology

Endpoints: Critical Preclinical Markers in Neurodegeneration Disease Assays
Drug Discovery

Endpoints: Critical Preclinical Markers in Neurodegeneration Disease Assays

Customized mRNA Processing for Improved Therapy Development and Manufacturing
Drug Discovery

Customized mRNA Processing for Improved Therapy Development and Manufacturing

Advanced In Vitro Screening of New Drugs for Proarrhythmic Activity
Drug Discovery

Advanced In Vitro Screening of New Drugs for Proarrhythmic Activity

Long-Lived RNA in Nerve Cells Can Last a Lifetime
Genome Editing

Long-Lived RNA in Nerve Cells Can Last a Lifetime

Antibiotic Hits Novel Target, a Lipid Enzyme, Defeats Resistant Bacteria in Mice
Drug Discovery

Antibiotic Hits Novel Target, a Lipid Enzyme, Defeats Resistant Bacteria in Mice

Bearing Fruit: Deep Apple Therapeutics Launches to Screen AI-Generated Virtual Libraries
Artificial Intelligence

Bearing Fruit: Deep Apple Therapeutics Launches to Screen AI-Generated Virtual Libraries

Expanding mRNA Manufacturing Techniques
Bioprocessing

Expanding mRNA Manufacturing Techniques

3D Cell Culture In Vitro Modeling Explores New Depths
Insights

3D Cell Culture In Vitro Modeling Explores New Depths

Decoding In Vitro Oncology Innovations: Organoids, OMICs, and Their Role in Early Drug Discovery and Clinical Applications
Multimedia

Decoding In Vitro Oncology Innovations: Organoids, OMICs, and Their Role in Early Drug Discovery and Clinical Applications

123...12Page 1 of 12

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up